These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16585125)

  • 1. A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia.
    You JH; Sahota DS; MoYuen P
    Hum Reprod; 2006 Jul; 21(7):1878-83. PubMed ID: 16585125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing drug-resistant essential menorrhagia without hysterectomy.
    Hurskainen R
    Best Pract Res Clin Obstet Gynaecol; 2006 Oct; 20(5):681-94. PubMed ID: 16731045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
    Ganz ML; Shah D; Gidwani R; Filonenko A; Su W; Pocoski J; Law A
    Value Health; 2013; 16(2):325-33. PubMed ID: 23538185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of menorrhagia with an LNG-IUS.
    Pakarinen P; Luukkainen T
    Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK.
    Clegg JP; Guest JF; Hurskainen R
    Curr Med Res Opin; 2007 Jul; 23(7):1637-48. PubMed ID: 17559758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Brown PM; Farquhar CM; Lethaby A; Sadler LC; Johnson NP
    BJOG; 2006 Jul; 113(7):797-803. PubMed ID: 16827763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of treatments for heavy menstrual bleeding.
    Spencer JC; Louie M; Moulder JK; Ellis V; Schiff LD; Toubia T; Siedhoff MT; Wheeler SB
    Am J Obstet Gynecol; 2017 Nov; 217(5):574.e1-574.e9. PubMed ID: 28754438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Levonorgestrel-releasing Intrauterine System (LNG-IUS) against Laparoscopic Assisted Supracervical Hysterectomy (LASH) for menorrhagia treatment: An economic evaluation.
    Laughton M; Patel NC; Dawoodbhoy FM; El-Ghrably S; Mahmud S
    J Gynecol Obstet Hum Reprod; 2021 Dec; 50(10):102229. PubMed ID: 34520876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
    Milsom I
    Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect on the treatment of menorrhagia by endometrial biopsy followed by contemporaneous insertion of the levonorgestrel intrauterine system.
    Baron YM; Craus J; Agius RC; Brincat M
    Gynecol Endocrinol; 2012 Sep; 28(9):694-8. PubMed ID: 22304721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.
    Hurskainen R; Teperi J; Rissanen P; Aalto AM; Grenman S; Kivelä A; Kujansuu E; Vuorma S; Yliskoski M; Paavonen J
    Lancet; 2001 Jan; 357(9252):273-7. PubMed ID: 11214131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.
    Hurskainen R; Teperi J; Rissanen P; Aalto AM; Grenman S; Kivelä A; Kujansuu E; Vuorma S; Yliskoski M; Paavonen J
    JAMA; 2004 Mar; 291(12):1456-63. PubMed ID: 15039412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
    Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
    BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.
    Roberts TE; Tsourapas A; Middleton LJ; Champaneria R; Daniels JP; Cooper KG; Bhattacharya S; Barton PM
    BMJ; 2011 Apr; 342():d2202. PubMed ID: 21521730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the levonorgestrel-releasing intrauterine system, hysterectomy, and endometrial ablation for heavy menstrual bleeding in a decision analysis model.
    Louie M; Spencer J; Wheeler S; Ellis V; Toubia T; Schiff LD; Siedhoff MT; Moulder JK
    Int J Gynaecol Obstet; 2017 Nov; 139(2):121-129. PubMed ID: 28796898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.
    Heliövaara-Peippo S; Hurskainen R; Teperi J; Aalto AM; Grénman S; Halmesmäki K; Jokela M; Kivelä A; Tomás E; Tuppurainen M; Paavonen J
    Am J Obstet Gynecol; 2013 Dec; 209(6):535.e1-535.e14. PubMed ID: 23999423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.
    Kaunitz AM; Stern L; Doyle J; Etschmaie MR
    Manag Care Interface; 2007 Mar; 20(3):47-50. PubMed ID: 17458481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.